Navigation Links
Former Deputy Commissioner of FDA Highlights Value of Small Distributors
Date:12/7/2011

WASHINGTON, Dec. 7, 2011 /PRNewswire/ -- Dr. Scott Gottlieb, the former deputy commissioner for medical and scientific affairs with the U.S. Food and Drug Administration, testified before the U.S. Senate Committee on Finance that small distributors play an important role in helping reallocate drugs to ensure that patients get the treatment they need. The committee hearing centered on how to address the drug shortage issues currently facing the nation.

A practicing physician and a resident fellow at the American Enterprise Institute, Gottlieb's prepared statements noted:

"Some also blame these shortages on what they refer to as 'manipulation' of drug middlemen or so-called 'gray market' distributors. However unpleasant, the markups charged by small distributors often reflect their higher costs, and aren't simply profiteering as has been alleged. ... Many small distributors routinely provide critical-need products to hospitals that cannot otherwise secure these same products from their primary wholesalers. This is especially important in rural areas. Moreover, small and independent distributors typically must purchase products at prices above the Wholesale Acquisition Costs. They cannot access drugs at the lower prices that GPOs negotiate with manufacturers. As a result, the difference between the higher prices charged by small distributors and those typically provided to hospitals by GPOs can often be misleading. What might appear as an enormously priced drug being offered by a small distributor may actually reflect an appropriate mark-up."

During the hearing, discussion focused on whether the FDA should set up a clearinghouse of scarce drugs for health care providers to help circumvent potential bottlenecks in distribution. Gottlieb pointed out that this is a role small distributors already play in the market.

"I would just add to that a lot of the reallocation that does take place in the market place is the small distributors reallocating product, and often times they have to acquire the product at a much higher price than what GPO might acquire it at," Gottlieb said. "I raise this just because there has been a lot of discussion about the so-called gray market and profiteering, but a lot of the small distributors who are acquiring the drugs at higher prices – and significantly higher prices – and then selling obviously them at higher prices as well, are performing an important market-clearing function."

Gottlieb's comments highlight the vital role small distributors play in health care – a role on which the National Coalition of Pharmaceutical Distributors has been working to educate people for several months.

About NCPD

The National Coalition of Pharmaceutical Distributors is a national trade association representing the wellbeing and interests of the independent and specialty pharmaceutical distribution industry. NCPD is dedicated to securing the pharmaceutical supply chain and is aggressively working to help enact federal legislation to revamp the nation's chain of custody laws for prescription pharmaceutical products.


'/>"/>
SOURCE National Coalition of Pharmaceutical Distributors
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Sunesis Pharmaceuticals to Present Interim Clinical Data From Voreloxin (Formerly SNS-595) Ovarian Cancer Trial at 44th ASCO Annual Meeting and Acute Myeloid Leukemia Trials at 13th EHA Congress
2. Sunesis Pharmaceuticals Presents Updated Clinical Data From Ongoing Phase 2 Trial of Voreloxin (Formerly SNS-595) in Ovarian Cancer Patients at the 44th ASCO Annual Meeting
3. Sunesis Pharmaceuticals Focuses Resources on Development of Voreloxin (Formerly SNS-595)
4. Sunesis Pharmaceuticals Presents Data from Clinical Trials of Voreloxin (formerly SNS-595) in Patients with Acute Myeloid Leukemia at the 13th Congress of the European Hematology Association
5. Michigan Life Science and Innovation Center Opens in Former Pfizer Facility
6. Peregrine Pharmaceuticals Appoints Former Genentech Senior Executive Dr. Robert Garnick as Head of Regulatory Affairs
7. NGM Biopharmaceuticals Appoints Dr. Arthur D. Levinson, Former Genentech CEO, to its Board of Directors
8. Former Miss USA Shawnae Jebbia Shines with Siemens Pure
9. Secure eHealth, LLC Engages as a Consultant GSI Health Whose Principal and CEO is the Former Senior Advisor to National Coordinator for Health Information Technology
10. Former Air Force Surgeon General Joins Integrated Medical Systems Advisory Board
11. SCAI Statement on the Hospitalization of Former President Bill Clinton
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/11/2017)...  Hill-Rom Holdings, Inc. ("Hill-Rom") (NYSE: HRC), today provided ... Piedras, Puerto Rico , where the ... Following a comprehensive onsite ... structural damage, temporary loss of power and minimal water ... manufacturing operations have resumed, and the company expects to ...
(Date:10/10/2017)... EXTON, Pa. , Oct. 10, 2017   ... leader in innovative solutions for injectable drug administration, today ... of West,s ID Adapter for improving the intradermal administration ... the Fourth Skin Vaccination Summit in May 2017 by ... Team Lead, Polio Department, World Health Organization (WHO), and ...
(Date:10/5/2017)... 5, 2017  In response to the nationwide ... Maxillofacial Surgeons (AAOMS) released prescribing recommendations that urge ... used as a first-line therapy to manage a ... Recognizing the value and importance ... "Opioid Prescribing: Acute and Postoperative Pain Management" stresses ...
Breaking Medicine Technology:
(Date:10/13/2017)... ... October 13, 2017 , ... Coveros, a leader in ... awarded a contract by the Center for Medicare and Medicaid Services (CMS). The ... enterprise use of Agile methodologies in a consistent and high value manner across ...
(Date:10/12/2017)... , ... October 12, 2017 , ... ... services for healthcare compliance program management, will showcase a range of technology and ... for Assisted Living (NCAL) Convention and Expo to be held October 14–18, 2017 ...
(Date:10/12/2017)... ... 12, 2017 , ... The company has developed a suite ... regulatory authorities worldwide. From Children’s to Adults 50+, every formula has been developed ... , These products are also: Gluten Free, Non-GMO, Vegan, Soy Free, Non-Dairy*, ...
(Date:10/12/2017)... ... October 12, 2017 , ... Asante, a ... health care, have expanded their existing home health joint venture through an agreement, ... been operating a joint venture home health company with Asante, delivering clinically integrated ...
(Date:10/12/2017)... ... 12, 2017 , ... HMP , a leader in healthcare events and ... Eddie Digital Award for ‘Best B-to-B Healthcare Website.’ Winners were announced during the Eddie ... annual award competition recognizes editorial and design excellence across a range of sectors. This ...
Breaking Medicine News(10 mins):